Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhenmin Ye

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Molecular Immunology|June 24, 2010
LFA-1 defect-induced effector/memory CD8+ T cell apoptosis is mediated via Bcl-2/Caspase pathways and associated with downregulation of CD27 and IL-15RZhenmin Ye, Meiqing Shi, Shulin Xu, et al.
Cancer Biotherapy & Radiopharmaceuticals|July 14, 2007
Adenovirus-mediated Il-24 expression suppresses hepatocellular carcinoma growth via induction of cell apoptosis and cycling arrest and reduction of angiogenesisXiaohua Wang, Zhenmin Ye, Jiang Zhong, et al.
Cellular & Molecular Immunology|May 1, 2008
Defect of CD8+ memory T cells developed in absence of IL-12 priming for secondary expansionZhenmin Ye, Shulin Xu, Terence Moyana, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 19, 2006
Intradermal vaccination of dendritic cell-derived exosomes is superior to a subcutaneous one in the induction of antitumor immunitySiguo Hao, Zhenmin Ye, Jicheng Yang, et al.
Cancer Investigation|March 10, 2010
Interleukin-17F suppresses hepatocarcinoma cell growth via inhibition of tumor angiogenesisYufeng Xie, Weihua Sheng, Jim Xiang, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 30, 2007
Human dendritic cells engineered to express alpha tumor necrosis factor maintain cellular maturation and T-cell stimulation capacityZhenmin Ye, Zhuang Chen, Amer Sami, et al.
Biochemical and Biophysical Research Communications|July 10, 2007
Alpha tumor necrosis factor contributes to CD8(+) T cell survival in the transition phaseMeiqing Shi, Zhenmin Ye, Keshav Sokke Umeshappa, et al.
Cancer Letters|September 16, 2008
Adenovirus-mediated ING4 expression suppresses lung carcinoma cell growth via induction of cell cycle alteration and apoptosis and inhibition of tumor invasion and angiogenesisYufeng Xie, Haifeng Zhang, Weihua Sheng, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 22, 2006
Oncolytic adenovirus-mediated E1A gene therapy induces tumor-cell apoptosis and reduces tumor angiogenesis leading to inhibition of hepatocellular carcinoma growth in animal modelZhenmin Ye, Xiaohua Wang, Siguo Hao, et al.
Immunology|February 3, 2007
CD4+ Th1 cells promote CD8+ Tc1 cell survival, memory response, tumor localization and therapy by targeted delivery of interleukin 2 via acquired pMHC I complexesHui Huang, Siguo Hao, Fang Li, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Molecular Immunology|June 24, 2010
LFA-1 defect-induced effector/memory CD8+ T cell apoptosis is mediated via Bcl-2/Caspase pathways and associated with downregulation of CD27 and IL-15RZhenmin Ye, Meiqing Shi, Shulin Xu, et al.
Cancer Biotherapy & Radiopharmaceuticals|July 14, 2007
Adenovirus-mediated Il-24 expression suppresses hepatocellular carcinoma growth via induction of cell apoptosis and cycling arrest and reduction of angiogenesisXiaohua Wang, Zhenmin Ye, Jiang Zhong, et al.
Cellular & Molecular Immunology|May 1, 2008
Defect of CD8+ memory T cells developed in absence of IL-12 priming for secondary expansionZhenmin Ye, Shulin Xu, Terence Moyana, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 19, 2006
Intradermal vaccination of dendritic cell-derived exosomes is superior to a subcutaneous one in the induction of antitumor immunitySiguo Hao, Zhenmin Ye, Jicheng Yang, et al.
Cancer Investigation|March 10, 2010
Interleukin-17F suppresses hepatocarcinoma cell growth via inhibition of tumor angiogenesisYufeng Xie, Weihua Sheng, Jim Xiang, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 30, 2007
Human dendritic cells engineered to express alpha tumor necrosis factor maintain cellular maturation and T-cell stimulation capacityZhenmin Ye, Zhuang Chen, Amer Sami, et al.
Biochemical and Biophysical Research Communications|July 10, 2007
Alpha tumor necrosis factor contributes to CD8(+) T cell survival in the transition phaseMeiqing Shi, Zhenmin Ye, Keshav Sokke Umeshappa, et al.
Cancer Letters|September 16, 2008
Adenovirus-mediated ING4 expression suppresses lung carcinoma cell growth via induction of cell cycle alteration and apoptosis and inhibition of tumor invasion and angiogenesisYufeng Xie, Haifeng Zhang, Weihua Sheng, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 22, 2006
Oncolytic adenovirus-mediated E1A gene therapy induces tumor-cell apoptosis and reduces tumor angiogenesis leading to inhibition of hepatocellular carcinoma growth in animal modelZhenmin Ye, Xiaohua Wang, Siguo Hao, et al.
Immunology|February 3, 2007
CD4+ Th1 cells promote CD8+ Tc1 cell survival, memory response, tumor localization and therapy by targeted delivery of interleukin 2 via acquired pMHC I complexesHui Huang, Siguo Hao, Fang Li, et al.
Pageof 2